Median-Based Incremental Cost-Effectiveness Ratio (ICER)

References

• Bang , H. and Tsiatis , A. A. 2002 . Median regression with censored cost data . Biometrics , 58 : 643 – 649 .
   PubMed Web of Science ®Google Scholar
• Black , W. C. 1990 . The CE plane: A graphic representation of cost-effectiveness . Med. Decision Making , 10 : 212 – 214 .
   PubMed Web of Science ®Google Scholar
• Bloomfield , D. J. , Krahn , M. D. Neogi , T. 1998 . Economic evaluation of chemotherapy with mitoxantrone plus prednisone for symptomatic hormone-resistant prostate cancer: Based on a Canadian randomized trial with palliative end points . J. Clin. Oncol , 16 : 2272 – 2279 .
   PubMed Web of Science ®Google Scholar
• Blumenschein , K. , Johannesson , M. , Yokoyama , K. K. and Freeman , P. R. 2001 . Hypothetical versus real willingness to pay in the health care sector: Results from a field experiment . J. Health Econ , 20 : 441 – 457 .
   PubMed Web of Science ®Google Scholar
• Briggs , A. 2000 . Economic evaluation and clinical trials: Size matters: The need for greater power in cost analyses poses an ethical dilemma . Br. Med. J , 321 : 1362 – 1363 .
   PubMed Web of Science ®Google Scholar
• Brookmeyer , R. 2005 . “ Median survival time ” . In Encyclopedia of biostatistics , Edited by: Armitage , P. and Colton , T. New York : John Wiley & Sons .
   Google Scholar
• Chaudhary , M. A. and Stearns , S. C. 1996 . Estimating confidence intervals for cost-effectiveness ratios: An example from a randomized trial . Stat. Med , 15 : 1447 – 1458 .
   PubMed Web of Science ®Google Scholar
• Dinh , P. and Zhou , X.-H. 2006 . Nonparametric statistical methods for cost-effectiveness analyses . Biometrics , 62 : 576 – 588 .
   PubMed Web of Science ®Google Scholar
• Drummond , M. F. , Sculpher , M. J. , Torrance , G. W. , ‘Brien , B. J. O and Stoddart , G. L. 2005 . Methods for the economic evaluation of health care programmes , 3rd , Oxford : Oxford University Press .
   Google Scholar
• Duan , N. 1983 . Smearing estimate: A nonparametric retransformation method . JASA , 78 : 605 – 610 .
   Web of Science ®Google Scholar
• Fan , M. Y. and Zhou , X. H. 2007 . A simulation study to compare methods for constructing confidence intervals for the incremental cost-effectiveness ratio . Health Serv. Outcomes Res. Method , 7 : 57 – 77 .
   Google Scholar
• Fenwick , E. , Claxton , K. and Sculpher , M. J. 2001 . Representing uncertainty: The role of cost-effectiveness acceptability curves . Health Econ , 10 : 779 – 787 .
   PubMed Web of Science ®Google Scholar
• Garber , A. M. and Phelps , C. E. 1997 . Economic foundations of cost-effectiveness analysis . J. Health Econ , 16 : 1 – 31 .
   PubMed Web of Science ®Google Scholar
• Gardiner , J. C. , Bradley , C. J. and Huebner , M. 2000 . “ The cost-effectiveness ratio in the analysis of health care programs ” . In Handbook of Statistics, Bioenvironmental and Public Health Statistics 18 Edited by: Rao , C. R. and Sen , P. K. 841 – 869 . North Holland
   Google Scholar
• Gardiner , J. C. , Huebner , M. , Jetton , H. and Bradley , C. J. 2001 . On parametric confidence intervals for the cost-effectiveness ratio . Biometrical J , 43 : 283 – 296 .
   Web of Science ®Google Scholar
• Gardiner , J. C. , Sirbu , C. M. and Rahbar , M. H. 2004 . Update on statistical power and sample size assessments for cost-effectiveness studies . Expert Rev. Pharmacoecon. Outcomes Res , 4 : 89 – 98 .
   PubMedGoogle Scholar
• Gold , M. R. , Sigel , J. E. , Russell , L. B. and Weinstein , M. C. , eds. 1996 . Cost-effectiveness in health and medicine , New York : Oxford University Press .
   Google Scholar
• Heitjan , D. F. , Moskowitz , A. J. and Whang , W. 1999a . Bayesian estimation of cost-effectiveness ratios from clinical trials . Health Econ , 8 : 191 – 201 .
   PubMed Web of Science ®Google Scholar
• Heitjan , D. F. , Moskowitz , A. J. and Whang , W. 1999b . Problems with interval estimates of the incremental cost-effectiveness ratio . Med. Decision Making , 19 : 9 – 15 .
   PubMed Web of Science ®Google Scholar
• Heshmat , S. 2003 . “ Cost-effectiveness analysis ” . In Encyclopedia of biopharmaceutical statistics , Edited by: Chow , S.-C. 363 – 368 . Informa Health Care .
   Google Scholar
• Hwang , J. T. G. 1995 . Fieller's problems and resampling techniques . Stati. Sin , 5 : 167 – 171 .
   Web of Science ®Google Scholar
• Jiang , G. , Wu , J. and Williams , G. R. 2000 . Fieller's interval and the bootstrap-Fieller interval for the incremental cost-effectiveness ratio . Health Serv. Outcomes Res. Method , 1 : 291 – 303 .
   Google Scholar
• Laska , E. M. , Meisner , M. , Siegel , C. and Stinnett , A. A. 1999 . Ratio-based and net benefit-based approaches to health care resource allocation: proofs of optimality and equivalence . Health Econ , 8 : 171 – 174 .
   PubMed Web of Science ®Google Scholar
• Neumann , P. J. 2004 . Why don't Americans use cost-effectiveness analysis? . Am. J. Managed Care , 10 : 308 – 312 .
   PubMed Web of Science ®Google Scholar
• O‘Brien , B. J. and Briggs , A. H. 2002 . Analysis of uncertainty in health care cost-effectiveness studies: An introduction to statistical issues and methods . Stat. Methods Med. Res , 11 : 455 – 468 .
   PubMed Web of Science ®Google Scholar
• Obenchain , R. L. 1999 . Resampling and multiplicity in cost-effectiveness inference . J. Biopharm. Stat , 9 : 563 – 582 .
   PubMedGoogle Scholar
• Obenchain , R. L. 2008 . ICE preference maps; Nonlinear generalizations of net benefit and acceptability . Health Serv Outcomes Res. Method , 8 : 31 – 56 .
   Google Scholar
• Obenchain , R. L. and Johnstone , B. M. 1999 . Mixed-model imputation of cost data for early discontinuers from a randomized clinical trial . Drug Information J , 33 : 191 – 209 .
   Web of Science ®Google Scholar
• Obenchain , R. L. and Sacristan , J. A. 1997 . In reply to “The negative side of cost-effectiveness ratios.” . J. Am, Med. Assoc , 277 : 1931 – 1933 .
   Google Scholar
• Ramsey , S. , Willke , R. Briggs , A. 2005 . Good research practices for cost-effectiveness analysis alongside clinical trials: The ISPOR RCT-CEA Task Force report . Value Health , 8 : 521 – 533 .
   PubMed Web of Science ®Google Scholar
• Rossner , M. , Van Epps , H. and Hill , E. 2007 . Show me the data . J. Cell Biol , 179 : 1091 – 1092 .
   PubMed Web of Science ®Google Scholar
• Siegel , J. E. , Weinstein , M. C. , Russell , L. B. and Gold , M. R. 1996 . For the Panel on Cost-Effectiveness in Health and Medicine. Recommendations for reporting cost-effectiveness analyses . J. Am. Med. Assoc , 276 : 1339 – 1341 .
   PubMed Web of Science ®Google Scholar
• Stinnett , A. A. 1996 . Adjusting for bias in C/E ratio estimates . Health Econ , 5 : 470 – 472 .
   PubMed Web of Science ®Google Scholar
• Stinnett , A. A. and Mullahy , J. 1997 . The negative side of cost-effectiveness analysis . J. Am. Med. Assoc , 277 : 1931 – 1932 .
   PubMed Web of Science ®Google Scholar
• Stinnett , A. A. and Mullahy , J. 1998 . Net health benefits: A new framework for the analysis of uncertainty in cost-effectiveness analysis . Med. Decision Making , 18 : S68 – S80 .
   PubMed Web of Science ®Google Scholar
• Tannock , I. F. , Osoba , D. Stockler , M. R. 1996 . Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: A Canadian randomized trial with palliative end points . J. Clin. Oncol , 14 : 1756 – 1764 .
   PubMed Web of Science ®Google Scholar
• Tollefson , G. D. , Beasley , C. M. Tran , P. V. 1997 . Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: Results of an international collaborative trial . Am. J. Psychiatry , 154 : 457 – 465 .
   PubMed Web of Science ®Google Scholar
• Van Hout , B. , Al , M. , Gordon , G. and Rutten , F. 1994 . Costs, effects and C/E-ratios alongside a clinical trial . Health Econ , 3 : 309 – 319 .
   PubMed Web of Science ®Google Scholar
• Wang , H. and Zhao , H. 2008 . A study on confidence intervals for incremental cost-effectiveness ratios . Biometrical J , 50 : 505 – 514 .
   PubMed Web of Science ®Google Scholar
• Weinstein , M. C. and Stason , W. B. 1977 . Foundations of cost-effectiveness analysis for health and medical practice . N. Engl. J. Med , 296 : 716 – 721 .
   PubMed Web of Science ®Google Scholar
• Zhao , H. , Bang , H. , Wang , H. and Pfeifer , P. E. 2007 . On the equivalence of some medical cost estimators with censored data . Stat. Med , 26 : 4520 – 4530 .
   PubMed Web of Science ®Google Scholar
• Zhao , H. and Tian , L. 2001 . On estimating medical cost and incremental cost-effectiveness ratios with censored data . Biometrics , 57 : 1002 – 1008 .
   PubMed Web of Science ®Google Scholar
• Zhao , H. , Zuo , C. , Chen , S. and Bang , H. In press . Nonparametric inference for median costs with censored data . Biometrics ,
   Web of Science ®Google Scholar
• Zhou , X. H. , Melfi , C. A. and Hui , S. L. 1997 . Methods for comparison of cost data . Ann. Intern. Med , 127 : 752 – 756 .
   PubMed Web of Science ®Google Scholar